We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Grants Totaling $500,000 for Researchers of AIDS Drugs

By Biotechdaily staff writers
Posted on 11 Jun 2003
A final call to submit applications for its Drug Discovery Development Research Grant Program has been announced by GlaxoSmithKline (GSK, London, UK). More...
Researchers working anywhere in the world toward breakthroughs in HIV/AIDS drug therapies have until July 31, 2003, to apply.

The one-time research grants range from US$25,000 to $150,000 and are intended to further the development of inventive treatments for HIV/AIDS, including therapies aimed at treating infection, prophylactic vaccines, or microbicides designed to prevent transmission of the virus. Since inception of the program, GSK has honored nine researchers for their groundbreaking work toward new pharmaceutical strategies to combat HIV.

Research grant recipients will be announced in September 2003 at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago (IL, USA). The grants will be paid on November 1, 2003. Detailed information as well as an application are available on the grant website (www.dddresearchgrant.com).

GSK >>



Related Links:
GlaxoSmithKline
Grant Info website

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Urine Analyzer
respons® UDS100
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.